Early neurodevelopmental markers predictive of mortality in infants infected with HIV‐1
Antolin M. Llorente(Centro Regional de Selección y Reproducción Animal), Samuel Adeniyi‐Jones, Claude A. Mellins(New York Psychoanalytic Society and Institute), Pim Brouwers(National Institutes of Health), Kathleen Malee(Northwestern University), Jesús Vélez-Borrás(University of Puerto Rico System), Manhattan Charurat(University of Illinois Chicago, Rockford campus), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Janice Ware(Boston Children's Hospital), Joan Hittleman(Binghamton University)
Cited by 38
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612